The specific transport media of the OncoMiD-Via® series have been specially developed to safely transport fresh tumour samples. It is crucial to maintain excellent viability of the cells contained in tumour samples during transport from the health care facility to the laboratory. To this end, Oncomedics has developed a series of cell type specific transport media that allow primary human tumour cells to remain viable for up to 48 hours post-surgery. OncoMiD-Via® media have been validated for the transport of:

• Breast tumours

	Cat#	Description	Cond.
	8 OMVIA2-Breast	OncoMid-Via for breast medium for transport of breast tumour samples	8vials
	23 OMVIA2-Breast		23vials

• Colon/rectum tumours

	Cat#	Description	Cond.
	8 OMVIA2	OncoMid-Via for colon medium for transport of colorectal tumour samples	8vials
	23 OMVIA2		23vials

• Prostate tumours

	Cat#	Description	Cond.
	8 OMVIA2-Prostate	OncoMid-Via for Prostate medium for transport of Prostate tumour samples	8vials
	23 OMVIA2-Prostate		23vials

• Glyoblastoma tumours

	Cat#	Description	Cond.
	8 OMVIA2-Glyoblastoma	OncoMid-Via for Glyoblastoma medium for transport of Glyoblastoma tumour samples	8vials
	23 OMVIA2-Glyoblastoma		23vials

• Lung tumours

	Cat#	Description	Cond.
	8 OMVIA2-Lung	OncoMid-Via for lung medium for transport of Lung tumour samples	8vials
	23 OMVIA2-Lung		23vials

• Ovarian tumours

	Cat#	Description	Cond.
	8 OMVIA2-Ovary	OncoMid-Via for Ovary medium for transport of Ovary tumour samples	8vials
	23 OMVIA2-Ovary		23vials

Storage: 2-8°C

For Reasearch Use Only 

For profit organization / Corporations, please contact tech@biotrend.com for quotation